Overview

Dex as Analgesic Adjuvant in OSA Patients

Status:
Withdrawn

Trial end date:
2015-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess whether intravenous peri-operative Dexmedetomidine reduces opioid requirements and or improves pain control after Uvulopalatopharyngoplasty (UPPP) in patients with obstructive sleep apnea (OSA).

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Montefiore Medical Center

Treatments:

Dexmedetomidine